Terms: = Small Cell Lung Cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
408 results:
1. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression.
Li L; Liu D; Chen T; Wei C; Qiao Y; Liu W; Liang Y; Liang Z; Chen C; Li D; Wu B; Zhao X; Huang D; Wu D
J Exp Clin Cancer Res; 2024 Jul; 43(1):200. PubMed ID: 39030638
[TBL] [Abstract] [Full Text] [Related]
2. UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/akt pathway.
He L; Chen H; Ruan B; He L; Luo M; Fu Y; Zou R
J Cancer Res Clin Oncol; 2024 Jul; 150(7):335. PubMed ID: 38969831
[TBL] [Abstract] [Full Text] [Related]
3. Evaluating the Clinical Characteristics and prognosis of Advanced Non-small cell lung cancer with Exon 20 Insertions.
Wang H; Xu Y; Lin J; Huang Y
Cancer Control; 2024; 31():10732748241262190. PubMed ID: 38857163
[TBL] [Abstract] [Full Text] [Related]
4. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract] [Full Text] [Related]
5. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract] [Full Text] [Related]
6. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment.
Huang X; Wu S; Chen S; Qiu M; Zhao Y; Wei J; He J; Zhao W; Tan L; Su C; Zhou S
Int Immunopharmacol; 2024 May; 132():111901. PubMed ID: 38554448
[TBL] [Abstract] [Full Text] [Related]
8. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients.
Wang N; Tan X; Cao S; Liu M
Pathol Res Pract; 2024 Apr; 256():155270. PubMed ID: 38552564
[TBL] [Abstract] [Full Text] [Related]
9. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
[TBL] [Abstract] [Full Text] [Related]
11. Discriminative and prognostic significance of LINC00623 for lung adenocarcinoma.
Lin Y; Dong C; Zhang J; Zhu Y
Ann Biol Clin (Paris); 2024 Feb; 81(6):591-601. PubMed ID: 38391164
[TBL] [Abstract] [Full Text] [Related]
12. G protein-coupled estrogen receptor activates PI3K/akt/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis.
Chen J; Zhao R; Wang Y; Xiao H; Lin W; Diao M; He S; Mei P; Liao Y
Mol Med; 2024 Feb; 30(1):28. PubMed ID: 38383297
[TBL] [Abstract] [Full Text] [Related]
13. Plin2 inhibits autophagy via activating akt/mTOR pathway in non-small cell lung cancer.
Wang Y; Hu Y; Xu R; Jin X; Jiao W
Exp Cell Res; 2024 Feb; 435(2):113955. PubMed ID: 38301990
[TBL] [Abstract] [Full Text] [Related]
14. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
15. DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote lung Squamous cell Carcinoma Malignancy and Chemoresistance.
Wang H; Zhang Y; Tian Y; Yang W; Wang Y; Hou H; Pan H; Pei S; Zhu H; Gu Z; Zhang Y; Dai D; Chen W; Zheng M; Luo Q; Xiao Y; Huang J
Cancer Res; 2024 Mar; 84(5):688-702. PubMed ID: 38199791
[TBL] [Abstract] [Full Text] [Related]
16. Schwann cell-derived exosomes promote lung cancer progression via miRNA-21-5p.
Zhou Y; Zhang Y; Xu J; Wang Y; Yang Y; Wang W; Gu A; Han B; Shurin GV; Zhong R; Shurin MR; Zhong H
Glia; 2024 Apr; 72(4):692-707. PubMed ID: 38192185
[TBL] [Abstract] [Full Text] [Related]
17. Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in lung cancer.
Geng P; Zhao J; Li Q; Wang X; Qin W; Wang T; Shi X; Liu X; Chen J; Qiu H; Xu G
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069368
[TBL] [Abstract] [Full Text] [Related]
18. The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature.
Shemesh R; Laufer-Geva S; Gorzalczany Y; Anoze A; Sagi-Eisenberg R; Peled N; Roisman LC
Sci Rep; 2023 Dec; 13(1):21544. PubMed ID: 38057448
[TBL] [Abstract] [Full Text] [Related]
19. Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy.
Alharthi NS; Al-Zahrani MH; Hazazi A; Alhuthali HM; Gharib AF; Alzahrani S; Altalhi W; Almalki WH; Khan FR
Pathol Res Pract; 2024 Jan; 253():154998. PubMed ID: 38056133
[TBL] [Abstract] [Full Text] [Related]
20. A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis.
Kong F; Yang X; Lu Z; Liu Z; Yang Y; Wang Z
PeerJ; 2023; 11():e16167. PubMed ID: 38047034
[TBL] [Abstract] [Full Text] [Related]
[Next]
